Biome Australia Limited (BIO.AX)
AUD 0.45
(0.0%)
AUD 0.45
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 13 Million AUD | 79.79% |
| 2023 | 7.23 Million AUD | 75.92% |
| 2022 | 4.11 Million AUD | 77.4% |
| 2021 | 2.31 Million AUD | 167.67% |
| 2020 | 866.13 Thousand AUD | 124.04% |
| 2019 | 386.59 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 6.01 Million AUD | 100.0% |
| 2024 FY | 13 Million AUD | 79.79% |
| 2024 Q4 | 6.99 Million AUD | 0.0% |
| 2024 Q1 | 3 Million AUD | -21.98% |
| 2023 Q2 | 3.38 Million AUD | 100.0% |
| 2023 FY | 7.23 Million AUD | 75.92% |
| 2023 Q4 | 3.85 Million AUD | 100.0% |
| 2023 Q3 | 1.92 Million AUD | -42.99% |
| 2023 Q1 | 1.69 Million AUD | -27.13% |
| 2022 Q1 | 901.3 Thousand AUD | -36.03% |
| 2022 FY | 4.11 Million AUD | 77.4% |
| 2022 Q4 | 2.31 Million AUD | 100.0% |
| 2022 Q3 | 1.15 Million AUD | -35.65% |
| 2022 Q2 | 1.8 Million AUD | 100.0% |
| 2021 Q3 | 704.42 Thousand AUD | -22.55% |
| 2021 Q4 | 1.4 Million AUD | 100.0% |
| 2021 FY | 2.31 Million AUD | 167.67% |
| 2021 Q1 | 454.78 Thousand AUD | 0.0% |
| 2021 Q2 | 909.56 Thousand AUD | 100.0% |
| 2020 FY | 866.13 Thousand AUD | 124.04% |
| 2019 FY | 386.59 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -648.585% |
| Acrux Limited | 5.09 Million AUD | -155.527% |
| Actinogen Medical Limited | 9.93 Million AUD | -30.986% |
| AnteoTech Limited | 460.39 Thousand AUD | -2725.582% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -400.74% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -76422.924% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | -223.662% |
| Amplia Therapeutics Limited | 4.45 Million AUD | -192.155% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -2647.095% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -70909.263% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -2061.593% |
| BTC Health Limited | 16.36 Thousand AUD | -79416.485% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | -74.437% |
| CSL Limited | 22.41 Billion AUD | 99.942% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | -13.055% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 85.247% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -461.783% |
| Dimerix Limited | 583.47 Thousand AUD | -2129.544% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 80.421% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -939.402% |
| Immuron Limited | 4.9 Million AUD | -165.333% |
| Immutep Limited | 3.5 Million AUD | -271.076% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -973.115% |
| Memphasys Limited | 60 Thousand AUD | -21581.495% |
| Nanollose Limited | 12.5 Thousand AUD | -103962.851% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 94.391% |
| Noxopharm Limited | 2.4 Million AUD | -441.975% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 5.31 Million AUD | -144.741% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | 1.39 Million AUD | -833.097% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -19670.36% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -1358.163% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -250.421% |
| PYC Therapeutics Limited | 22.05 Million AUD | 41.028% |
| Race Oncology Limited | 4 Million AUD | -224.941% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -4247.487% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Starpharma Holdings Limited | 8.28 Million AUD | -56.942% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 97.381% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -8444.993% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -13600.498% |